Summary & Key Takeaways ​

• OpenAI and Molecule.one developed a near-autonomous AI chemist system.
• The AI, powered by GPT-5.4, improved a challenging medicinal chemistry reaction.
• This advancement has significant implications for drug discovery and development processes.
• The research showcases AI's growing capabilities in complex scientific domains, moving towards autonomy.

Our Commentary ​

This is genuinely mind-blowing. An AI chemist, near-autonomous, improving drug reactions? We're not just talking about code generation anymore; this is fundamental scientific discovery. I genuinely don't know how to feel about agents churning away at 3am while nobody's watching, but the potential here is immense. It's a paradigm shift.